Abstract:Background: The purpose of this research was to evaluate the effect of clofazimine on drug-resistant tuberculosis treatment outcomes. Methods: A systematic search was conducted in the PubMed, Web of Science and EMBASE databases to identify eligible studies published up to July 10, 2021. The search terms were as follows: "clofazimine," "tuberculosis," "multidrug resistant tuberculosis" or "extensively drug resistant tuberculosis" and their synonyms or similar words. Two researchers independently screened the titles, abstracts, and full texts for inclusion. Meta-analysis was performed with Stata version 16.0 (Stata Corp., College Station, Texas, USA). Risk ratios (RRs) with 95% CIs were calculated to evaluate the treatment outcome.Results: Eight studies including 3219 participants were included in the meta-analysis. The meta-analysis found that the rates of treatment completion was higher in patients receiving clofazimine-containing regimens than in those not receiving clofazimine-containing regimens (RR: 1.185 (1.060-1.325), P = 0.003). Significant reduction in treatment failure (RR: 0.598 (0.473-0.756), P < 0.001) was found in the clofazimine treatment group. The subgroup analyses of randomized controlled trials (RCTs) found a higher rates of favorable outcomes, treatment completion and cure in the clofazimine group than in the control group (RR: 1.203 (1.029-1.407), P = 0.020; RR: 3.167 (2.043-4.908), P < 0.001; and RR: 1.251 (1.031-1.518), P = 0.023, respectively). Patients receiving clofazimine had a lower risk of treatment failure than those not receiving clofazimine (RR: 0.529 (0.454-0.616), P < 0.001). However, clofazimine treatment did not have a statistically significant effect on all-cause mortality in RCTs. Conclusions: This study demonstrated that compared with patients who do not receive clofazimine, this drug has the potential to achieve a higher favorable outcome, treatment completion and cure rates, and a lower treatment failure risk among drug-resistant tuberculosis cases.(c) 2022 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

In vivo effect of clofazimine in the lysosomal enzyme level and immune complex phagocytosis of mouse peritoneal macrophages.

Phagocytosed Clofazimine Biocrystals Can Modulate Innate Immune Signaling by Inhibiting TNFα and Boosting IL-1RA Secretion

Increased phagocytosis and growth inhibition of Encephalitozoon cuniculi by LPS-activated J774A.1 murine macrophages

Synergistic Activity of Clofazimine and Clarithromycin in an Aerosol Mouse Model of Mycobacterium avium Infection

Impacts of Clofazimine on the Treatment Outcomes of Drug-Resistant Tuberculosis

Clofazimine alters the energy metabolism and inhibits the growth rate of a human lung-cancer cell line in vitro and in vivo

Effects of Recombinant Interferon-Gamma and Chemotherapy with Isoniazid and Rifampicin on Infections of Mouse Peritoneal-Macrophages with Listeria-Monocytogenes and Mycobacterium-Microti Invitro

Effects of mesoporous SiO2-CaO nanospheres on the murine peritoneal macrophages -- Candida albicans interface

Analysis of cytolytic effects of MazF protein of L.interrogans on macrophages

Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections

Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized Trial

Interplay of human macrophage response and natural resistance of L. (V.) panamensis to pentavalent antimony

Immunosuppressants alter the immune response associated with Glucantime® treatment for Leishmania infantum infection in a mouse model

Development of in Vitro Macrophage System to Evaluate Phagocytosis and Intracellular Fate of Penicillium Marneffei Conidia

Varying effects of common tuberculosis drugs on enhancing clofazimine activity in vitro <subtitle>Effect of tuberculosis drugs on clofazimine activity</subtitle>

In vivo and in vitro Leishmania amazonensis infection induces autophagy in macrophages

Clofazimine has delayed antimicrobial activity against Mycobacterium tuberculosis both in vitro and in vivo

Enhancing effects of gamma interferon on phagocytic cell association with and killing of Trypanosoma cruzi

Phagosome-Lysosome Fusion and Cyclic Adenosine 3'-5'-monophosphate in Macrophages Infected with Mycobacterium-Microti, Mycobacterium-Bovis Bcg or Mycobacterium-Lepraemurium

Comparison of biosynthetic zinc oxide nanoparticle and glucantime cytotoxic effects on Leishmania major (MRHO/IR/75/ER)

Investigation into the Solid and Solution Properties of Known and Novel Polymorphs of the Antimicrobial Molecule Clofazimine